|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||14.90 - 16.23|
|52 Week Range||6.44 - 25.03|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||20.66|
Canopy Growth's Acreage Acquisition Boosts SentimentThe gains The cannabis sector appeared to show optimism after Canopy Growth (WEED)(CGC) announced that it would acquire Acreage Holdings (ACRGF), a US multi-state cannabis operator with
CHICAGO and VANCOUVER, British Columbia, April 18, 2019 -- Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods.
LOS ANGELES, April 15, 2019 /PRNewswire/ -- Luxury cannabis leader Beboe announces the launch of Beboe Therapies, a CBD-infused skincare collection that combines the brand's unmatched plant expertise and quality standards. Beboe Therapies cultivates the purest formulas to deliver the magical benefits of CBD. Beboe offers the sophisticated cannabis consumer an experience unlike any other on the market.
Cannabis stocks were mostly lower Thursday, a day after the top justice official in the U.S. offered muted support for a bill that would protect companies in states that have legalized weed.
CGC, CRON, and GTBIF Reverse Their Falling Streaks on April 12Reversal The cannabis sector has been under pressure in April, with major cannabis stocks delivering negative returns so far in the month. However, on the morning of April 12, the
One industry that's been beaten to a pulp is the vertically integrated dispensary space in the United States. It requires significant amounts of capital to construct greenhouses, operate processing facilities, and renovate or construct dispensaries for the sale of cannabis. But none of this has been an issue for Green Thumb Industries (GTBIF).During the fourth quarter, Green Thumb's sales grew by 237% to $20.8 million, including 21% sales growth from the sequential quarter. More specifically, the company wound up opening seven Rise retail stores during the fourth quarter, bringing its total number of locations to 14. Furthermore, more than 5 new store openings are planned for the second quarter 2019 including Rise stores across Ohio, Pennsylvania, and Florida. Overall, Green Thumb plans to open 15 to 20 new stores in 2019.Seaport analyst Brett Hundley believes Green Thumb stock could soar about 25% over the next 12 months, as he reiterates a Buy rating rating and raising his price target for the stock to $18.00 (from $16.00). (To watch Hundley's track record, click here)Hundley commented, "One of the things that we have liked about GTBIF from day one is its focus on building CPG brands across the US dispensary space. This is where we ultimately expect margin strength to reside, despite most of the supply chain profitability being located within the retail segment, at present. Moreover, we expect the company's development of distinct wholesale and retail businesses to offer future optionality alongside relative protection from regulatory risk, depending on how the federal US government's views evolve.""If there is any knock on Green Thumb, it is that the company's path to brand building in mainly limited license medical states may have afforded it more ease relative to building brands in open states like California, for instance. This argument may hold some weight, but we would also hurry on to mention that competitors in limited license states tend to many times be better capitalized and managed, relative to open states. GTBIF has a wealth of executive talent in place, and we expect recent acquisitions like Beboe to aid in future wholesale expansion efforts, to include what we expect will be a high-end differentiated CBD offering for omni-channel outlets, ahead," the analyst continued.All in all, with the U.S. marijuana industry having a considerably larger peak sales potential than Canada (if legal), there's a lot of excitement surrounding Green Thumb's rapidly expanding branded retail operations.Wall Street’s confidence on the cannabis stock speaks for itself; GTBIF has received 5 'buy' ratings in the last six months, with no 'sell' or 'hold' ratings. Meanwhile, the $20.55 (C$27.40) consensus price target suggests a potential upside of nearly 40% from the current share price.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. More recent articles from Smarter Analyst: * Jeff Bezos Is Leading Amazon (AMZN) in the Right Direction * Why Autonomous Could Be a Strong Driver for Nvidia (NVDA) Stock * Microsoft (MSFT) Stock's Big Rally Should Continue * Oppenheimer Still Sees 40% Upside for Tesla (TSLA) Stock
Green Thumb Industries: Analysts' Views in April(Continued from Prior Part)Lower valuations Green Thumb Industries (GTBIF) has experienced selling pressure in April. However, the company isn’t alone. The overall cannabis sector faced weakness. Most
Green Thumb Industries: Analysts' Views in AprilGreen Thumb Industries So far, Green Thumb Industries (GTBIF) (GTII) has experienced weakness in April. The stock has fallen nearly 7% in April. The company is among a few US consumer goods cannabis
Marijuana stocks have become much more accepted by mainstream investors in the past few years. However, just because investing in cannabis is getting more common doesn't mean it's not dangerous territory for investors.A parade of marijuana stocks has listed on major U.S. exchanges since the beginning of 2018. In addition, a growing number of Wall Street analysts are now covering marijuana stocks. Cannabis investors are no longer automatically smirked at. Unfortunately, there are still plenty of dangers lurking in the cannabis market. The Dangers Of OTC StocksMarijuana stocks like Canopy Growth Corp (NYSE: CGC), Tilray (NASDAQ: TLRY) and Aurora Cannabis (NYSE: ACB) have gained legitimacy in the past year by transitioning to the NYSE and Nasdaq exchanges.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 AI Stocks to Watch with Strong Long-Term Narratives At the same time, U.S. multi-state cannabis operators like Curaleaf Holdings (OTC: CURL), Medmen Enterprises (OTC: MMNFF) and Green Thumb Industries (OTC: GTBIF) are currently relegated to trading on the OTC market. Since these companies are technically running U.S. businesses that contravene federal laws, they will likely stay on the OTC market for the time being.OTC stocks have a somewhat poor reputation among average investors. Many OTC stocks trade for under $1 per share, and it's common for OTC stocks to provide little financial information to investors. The information these companies do provide is often unreliable.As a result, it can be difficult for investors to get a clear picture of what's going on at companies with OTC stocks. Essentially, all companies need to do to list on the OTC is fill out a request form.Most cannabis stocks are far from the typical, sketchy, OTC-listed stock. However, that doesn't mean all the dangers mentioned above don't still apply to them. Medmen's Fake NewsSince information about OTC-listed stocks can be difficult to obtain, greedy traders and greedy companies can take advantage of the situation. Companies listed on the OTC markets are notorious for carrying out "pump-and-dump" schemes. Those schemes involve companies or third parties flooding message boards and social media platforms with fake news about a stock to drive its price higher. These companies or third parties will then cash out at the peak, and other buyers of the stock will get burned.Pump-and-dump schemes are technically illegal. But so is driving over the speed limit, and plenty of people still get away with it. And if you think these types of stock-promotion schemes aren't used to pump and dump reputable cannabis stocks, you're wrong.Seven analysts are currently covering Medmen (OTC: MMNFF), and six of the seven analysts recommend that investors buy MMNFF stock. Yet just last month, Medmen admitted to using an agreement with a company called Winning Media to promote MMNFF stock. In a press release, Medmen said it "disclaims any potentially exaggerated or misleading statements contained in the materials" distributed online by Winning Media. But at that point, the damage to the owners of MMNFF stock may have already been done.Medmen will likely be particularly careful in the future about the types of public relations deals that it makes. However, given how thinly-traded the OTC market is, stock promoters don't need companies' permission to promote stocks. The promoters can simply take a position in a stock, spread fake news online and cash out. The company may be none the wiser. Avoiding Pump-and-Dump Cannabis StocksFortunately for cannabis investors, there are ways to avoid being misled by promoters. According to Todd Fromer, the managing partner of KCSA Strategic Communications, common sense can go a long way for cannabis-stock investors. Fromer says investors can watch for certain red flags when reading about marijuana stocks online.First, only trust reputable news sources. A good rule of thumb is to consider whether or not you've heard of the website before. For example, a news article on Bloomberg or CNBC is fine. An article on GetRichQuickWithPennyStocks.com may not be.Second, look for disclosures indicating the article is an advertisement. Finally, use common sense to identify stories that are too good to be true. Actual journalists will almost never make claims like "1000% upside" or "guaranteed profits.""As the cannabis sector continues to gain momentum it's critical that both investors and company management remain vigilant," Fromer recently wrote.Marijuana stocks have taken major strides in recent quarters towards leaving their shady past behind. Unfortunately, some U.S. cannabis companies still have a long way to go. In the meantime, just because cannabis stocks are getting much more mainstream media coverage doesn't mean investors can let their guard down. Don't believe everything you read about marijuana stocks.As of this writing, Wayne Duggan did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Best Dividend Stocks to Buy for Every Investor * 7 Catalysts That Will Send Marijuana Stocks Soaring in 2019 * 8 Risky Stocks to Watch as Earnings Season Kicks Off Compare Brokers The post Don't Believe Everything You Read About Marijuana Stocks appeared first on InvestorPlace.
CHICAGO and VANCOUVER, British Columbia, April 11, 2019 -- Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company.
Cannabis stocks were mixed on Wednesday, with Green Thumb Industries Inc. a standout after posting a big jump in revenue in its latest quarter, while packaging company KushCo fell sharply after saying 2018 losses may double after it uncovered accounting errors.
Do Cannabis Stocks Look Cheap at These Valuations?(Continued from Prior Part)Trading compsThe cannabis sector’s median forward EV-to-EBITDA (enterprise value-to-earnings before interest, tax, depreciation, and amortization) multiple was 23.6x,
Green Thumb Industries Inc. reported Tuesday fourth-quarter net losses attributable to the company of $3.1 million, or 2 cents a share, compared with $2.4 million, but did not include a per-share figure, in the year-prior quarter. Green Thumb reported net losses including non-controlling interest of $8.9 million for the fourth quarter. Net discounts that it did not describe in the earnings release, Green Thumb said revenue rose to $20.7 million from $6.2 million in the year-ago quarter. The company, which lists on the Canadian Securities Exchange under the ticker symbol GTII as well as over the counter in the U.S., does not receive enough analyst coverage to generate a reliable FactSet consensus estimate. Green Thumb stock has gained 128% in the past year. The ETFMG Alternative Harvest ETF has gained 32%, as the Horizons Marijuana Life Sciences Index ETF rose 46%.
Disciplined Capital Allocation Continues to Drive Strategy to Distribute Brands at Scale in 2019 Fourth quarter revenue of $20.8 million, 21% sequential growthFull year.
There's No End in Sight for Tilray's SlumpTilray continues to slump There seems to be no end in sight for Tilray’s (TLRY) slump. The stock continued bleeding on April 5, with a 2.8% decline in the first half of the day. The trend has continued for
CTST, ACB, HEXO, CRON, and Others Bleed on April 2(Continued from Prior Part)Gains The overall cannabis sector experienced weakness during the first half of April 2. Most of the major stocks are trading in the negative territory. However, not all of
POINT ROBERTS, Wash. and DELTA, British Columbia, March 26, 2019 -- Investorideas.com, a leading investor news resource covering hemp and cannabis stocks continues with our two.
It's a no-go for recreational marijuana in the Garden State for now. And several marijuana stocks are feeling the sting of the state's delay.
Last week, the bill that will allow the good people of New Jersey to legally buy and consume adult-use cannabis, cleared the Assembly Appropriations Committee. Investors who have been following legalization developments in New Jersey are likely encouraged by this recent move.
Cannabis Sector: Mixed Bag Last WeekCannabis sector last weekThe week ending March 22 was a mixed bag for the cannabis sector. The cannabis sector ETFs ended largely in the negative territory, which mimicked the broader market’s direction. The
CORAL GABLES, FL / ACCESSWIRE / March 22, 2019 / The marijuana stock market has garnered much of its notoriety due to investors focusing on the top players on the cannabis industry. Over the course of the last few months, these companies often have been the pure-play growers of the cannabis plants, as well as businesses that invest in the marijuana industry. Having said that, there is a large amount of potential within lesser-known companies in the cannabis sector, namely ancillary companies which fulfill a crucial role for the industry.
CRON, ACB, CGC, APHA, and Other Cannabis Stocks Trend Lower(Continued from Prior Part)GainersIn the previous part of this series, we saw that most cannabis stocks (MJ) were trending lower today, but there were some gains as well.The gainers include
CORAL GABLES, FL / ACCESSWIRE / March 19, 2019 / What's truly incredible about the marijuana stock market is the fact that even though the cannabis industry is still very much in its infancy, cannabis companies consistently attract significant investor attention. Following the passing of the U.S. Farm Bill, cannabis companies have had the opportunity to build out their industrial hemp production to allow for the manufacturing of products containing hemp-derived CBD. Integrated Cannabis Solutions Inc (IGPK), Tilray Inc (NASDAQ:TLRY), Green Thumb Industries Inc (GTBIF), and Trulieve Cannabis Corp (OTC PINK: TCNNF) (TRUL.CN) are 4 pot stocks to watch on Tuesday.
CHICAGO and VANCOUVER, British Columbia, March 19, 2019 -- Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a national cannabis consumer packaged goods company and.
According to a recent Forbes article, North America is expected to become the single largest legal cannabis market in the world, growing to approximately $47.3 billion by 2027. To serve this billion dollar market, a number of North American marijuana companies are building out innovative, premium cannabis retail brands across the continent. In this report, we examine some of the fastest growing North American cannabis retailers preparing to dominate the Canadian and U.S. legal marijuana markets. Westleaf Inc. (WL.V) (WSLFF), a vertically integrated Canadian cannabis company focused on innovative retail experiences and engaging cannabis brands as well as cultivation, production and extraction of cannabis products, is quickly becoming one of Canada’s largest premium cannabis retailers.